Physician

Joseph Charles Shanahan, MD

According to 2025 Medicare claims, Joseph Shanahan, MD (NPI: 1043394901) practices rheumatology in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is SHANAHAN RHEUMATOLOGY AND IMMUNOTHERAPY, PLLC (NPI: 1912235268; TIN: 270845895) and primary practice location at 27713-5222.

Shanahan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 581 traditional Medicare patients, billed 309,185 HCPCS/CPT codes, and received $2,909,121 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 4,583 prescription claims across 635 beneficiaries totaling $6,296,999 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2017 DME data shows 139 claims. Open Payments data shows 75 records totaling $15,796. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,210,733 to $6,296,999. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.1M$4.2M2015 Medicare payment: $1,784,208 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,223,452 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,829,933 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,389,663 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,183,795 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $4,129,835 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,069,919 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,570,511 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,725,316 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,909,121 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201562997,987$1,784,208
2016548101,793$2,223,452
201757799,120$2,829,933
2018650150,609$3,389,663
2019669225,260$4,183,795
2020649292,228$4,129,835
2021615286,166$4,069,919
2022604277,596$3,570,511
2023550291,093$3,725,316
2024581309,185$2,909,121

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.1M$6.3M2015 Drug cost: $2,210,733 (USD; Tot_Drug_Cst)2016 Drug cost: $2,396,353 (USD; Tot_Drug_Cst)2017 Drug cost: $2,976,414 (USD; Tot_Drug_Cst)2018 Drug cost: $2,970,119 (USD; Tot_Drug_Cst)2019 Drug cost: $3,513,351 (USD; Tot_Drug_Cst)2020 Drug cost: $4,366,914 (USD; Tot_Drug_Cst)2021 Drug cost: $4,371,513 (USD; Tot_Drug_Cst)2022 Drug cost: $4,899,229 (USD; Tot_Drug_Cst)2023 Drug cost: $5,787,687 (USD; Tot_Drug_Cst)2024 Drug cost: $6,296,999 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154705,295$2,210,733
20164665,754$2,396,353
20174735,639$2,976,414
20185105,316$2,970,119
20195344,775$3,513,351
20205374,730$4,366,914
20215164,439$4,371,513
20225474,205$4,899,229
20235924,315$5,787,687
20246354,583$6,296,999

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$74K$147K2015 Medicare payment: $109,649 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $147,191 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $76,059 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R184$109,649
2016N/R270$147,191
2017N/R139$76,059
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more171253$126
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more452780$89
96413Administration of chemotherapy into vein, 1 hour or less135861$87
96401Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle114552$50
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's396733$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab1584,690$1,675,842
Xeljanz XrTofacitinib Citrate1323,960$767,174
Orencia ClickjectAbatacept401,848$373,333
Cosentyx Sensoready (2 Pens)Secukinumab401,232$316,377
OtezlaApremilast631,890$304,944

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.75$15,796GlaxoSmithKline, LLC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Joseph Charles Shanahan, MD?

Tedicare shows public-source Medicare data for Joseph Charles Shanahan, MD (NPI 1043394901), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joseph Charles Shanahan, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Joseph Charles Shanahan, MD?

Joseph Charles Shanahan, MD is linked to SHANAHAN RHEUMATOLOGY AND IMMUNOTHERAPY, PLLC (billing NPI 1912235268) in the available physician profile data.

Does Joseph Charles Shanahan, MD have Open Payments data?

Joseph Charles Shanahan, MD has 75 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.